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Differential Expression of D-Type Cyclins in HaCaT
Keratinocytes and in Psoriasis
No´ra Belso˜1, Ma´rta Sze´ll2, Andor Pivarcsi2, Korne´lia Kis3, Bernadett Kormos1, Anna Sz. Kenderessy1, Attila
Dobozy1,2, Lajos Keme´ny1,2 and Zsuzsanna Bata-Cso¨rgo˜1,2
In this study, we show that the G0–G1/S phase of HaCaT keratinocyte cell cycle is characterized by D1-type cyclin
expression, whereas during the repeated rapid turnover of highly proliferating cells, the expression of cyclins
D2 and D3 dominates. Knocking down cyclin D1 mRNA resulted in no change of cell proliferation and
morphology, indicating that D2 and D3 cyclins could substitute for D1 in driving the cell cycle. Increased
numbers of cyclin D1-expressing keratinocytes were found in the basal layers of the lesional psoriatic epidermis
compared to both normal and non-lesional epidermis without increased expression of cyclin D1 mRNA,
suggesting a possible dysfunction in the degradation of cyclin D1 protein. We also detected a significant
increase in cyclin D2 and D3 mRNA expressions in psoriatic epidermis compared to normal epidermis with no
difference in protein expressions. Blocking a5-integrin function by a neutralizing antibody in HaCaT
keratinocytes downregulated the expression of cyclin D1 mRNA without affecting the expressions of cyclin
D2 and D3 indicating a regulatory role for a5-integrin in the expression of cyclin D1. Our data suggest a possible
role for D-type cyclins in the excessive basal-cell proliferation and perturbed keratinocyte differentiation in the
psoriatic epidermis.
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INTRODUCTION
D-type cyclins are one of the key components of the cell-
cycle machinery (Sherr and Roberts, 2004). Three D cyclins,
cyclins D1, D2, and D3, operate in mammalian cells and play
a major role in positive regulation of G1 progression
(Ciemerych et al., 2002). In the developing skin of mice,
cyclin D1 is present in keratinocytes and is absent from
developing hair follicles, whereas cyclin D2 exhibits an
opposite pattern of expression (Aguzzi et al., 1996). In
mice, cyclin D1 localizes to the proliferative layers in stratified
squamous epithelia and in columnar gastrointestinal epithe-
lium, whereas cyclin D3 is present in the adjacent compart-
ments where differentiation takes place (Bartkova et al., 1998).
Quiescent (G0 phase) basal K1/K10
 (keratin1/keratin10-
negative) keratinocytes freshly isolated from human skin
express, D1- but not D2-type cyclin when they almost
synchronously traverse from G0–G1 into an initial cell cycle
as a result of a wound response to disaggregation and in vitro
culturing. As keratinocytes enter subsequent cell cycles, D1
expression disappears and cyclin D2 becomes clearly
detectable. The differential expression of cyclins D1 and
D2 in keratinocytes suggests specific functions for D-type
cyclins and provides direct evidence that the G0–G1–S
progression of quiescent keratinocytes is distinct from the
G1–S traverse of already cycling cells (Bata-Csorgo et al.,
1996). Recently, it was shown that cyclin D1-mediated
proliferation predominantly occurs in the immediate progeny
of the stem cell-rich bulge cells in human hair follicle,
indicating that cyclin D1 may be important for cells to exit
the stem-cell compartment (Xu et al., 2003). In contrast,
cyclin D3 was reported to accumulate to high levels in the
stratified squamous epithelial layers of postreplicative,
differentiating cells in mice (Bartkova et al., 1998). To
understand better cyclin D functions in keratinocytes, we
followed their expression in synchronized HaCaT keratino-
cyte cultures. To determine whether cyclin D1 function was
essential for quiescent HaCaT keratinocytes to proliferate
after release from contact inhibition and serum starvation, we
knocked down the expression of cyclin D1 mRNA in
synchronized HaCaT keratinocytes by RNA interference.
Psoriasis is considered to be a multifactorial inflammatory
skin disease with distinct hyperproliferation of the normally
quiescent basal keratinocyte population which contains the
keratinocyte stem cells (Bata-Csorgo et al., 1993). Although
there is strong evidence that dysregulated inflammation plays
a pivotal role in disease development and maintenance, data
indicate that epidermal abnormalities contribute to disease
susceptibility. Fibronectin as a prominent component of
extracellular matrix has been shown to increase cell-cycle
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entry among uninvolved but not normal keratinocytes
(Bata-Csorgo et al., 1998). Concordantly, a5-integrin the
receptor of fibronectin, but not a2 or a3, is overexpressed in
the in vivo non-lesional psoriatic epidermis (Pellegrini et al.,
1992; Bata-Csorgo et al., 1998). The role of abnormal
a5-integrin expression in psoriasis pathogenesis is further
supported by the fact that mice with forced suprabasal
integrin expression exhibit epidermal hyperproliferation,
perturbed keratinocyte differentiation, and skin inflammation
(Carroll et al., 1995). Because D-type cyclins are major
sensors of cell cycle driving environmental signals, we
characterized the expression of D-type cyclins in psoriasis
and examined the role of a5-integrin in the regulation of
cyclin D1 mRNA expression.
RESULTS
The G0–G1/S phase of HaCaT keratinocyte cell cycle is
characterized by the appearance of D1-type cyclin expression,
whereas during the repeated rapid turnover of highly
proliferating cells expression of cyclins D2 and D3 dominates
To characterize cell cycle-specific D-cyclin expression in
HaCaT keratinocytes, we used synchronized cell cultures
(n¼3). An almost complete cell-cycle withdrawal can be
achieved in these cultures by contact inhibition and serum
starvation, as we have shown previously by cell-cycle
analysis of PI-stained cells (Pivarcsi et al., 2001). Quiescent
cells at the time of release from growth inhibition express
almost undetectable cyclin D1 mRNA. A gradual increase in
cyclin D1 mRNA can be detected in the cells between 24 and
72 hours after release from cell quiescence, closely followed
by increasing number of cells entering S phase. Cyclin D1
expression is preceded by the increase of a5-integrin mRNA
in the cells; at the same time mRNAs for the early
differentiation markers K1/K10 substantially decrease. By
the end of a 1-week culture period, keratin expression
reoccurs in the cells parallel to suppression of a5-integrin and
cyclin D1 expression and with reduction of proliferation
(Pivarcsi et al., 2001). The expression of cyclins D1, D2, and
D3 at the mRNA levels were determined in synchronized
HaCaT keratinocyte cultures at 0, 12, 24, 36, 48, 72, 96, and
168hours after the end of the synchronization process, using
real-time reverse transcription PCR (RT-PCR). The serum-
starved, contact-inhibited HaCaT keratinocytes, similar to our
previous observation, expressed a very low level of cyclin D1
mRNA (0 hour sample), which increased significantly with
time after passaging and serum re-addition. The highest level
of cyclin D1 mRNA expression (10.7-fold increase compared
to 0 hour samples) was detected 24 hours after release from
cell quiescence when cells started to proliferate (Figure 1a).
Cyclin D2 and D3 mRNAs also showed low levels of
expression in quiescent cells (0 hour). Cyclin D2 and D3
mRNA levels gradually increased in the cells after release
from cell quiescence, but their peak expression occurred at
48–72 hours in already proliferating cells (Figures 1b and c).
Both cyclin D2 (Figure 1b) and cyclin D3 (Figure 1c)
mRNA expressions showed maximum levels at 48 and
72 hours (9.62- and 9.23-fold and 10.22- and 13.22-fold
increases, respectively, compared to the 0 hour samples). As
cell cultures became confluent mRNA levels for all cyclins
have decreased.
The levels of cyclin D1, D2, and D3 protein expressions
showed similar kinetics compared to the mRNA expressions
when analyzed by flow cytometry (n¼ 3). Cyclin D1
expression was low in serum-starved quiescent cells
(5.7474.01% of all cells expressed cyclin D1) (Figure 2a),
at the same time cyclin D2 and D3 proteins showed higher
expressions (41.2576.31% cells were positive for D2 and
27.3271.38% were positive for D3 cyclin) (Figure 2c). Both
cyclin D1 and D2 expressions increased considerably after
release from cell quiescence (Figures 2a and b). The highest
level of cyclin D1 protein expression (2.82-fold increase in
geometric mean fluorescence intensity/GeoMean/compared
to the 0 hour samples) was detected 24 hours after release
from cell quiescence (28.9773.3% cells were positive for
cyclin D1) (Figure 2a). Cyclin D2 expression peaked later at
72 hours in the already highly proliferative cultures (5.17-fold
increase in GeoMean at 72 hours compared to 0 hour
samples, Figure 2b), where 83.4173.6% of the cells showed
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Figure 1. Cyclin D1, D2, and D3 mRNA expressions in synchronized HaCaT
keratinocytes. HaCaT keratinocytes (n¼ 3) were arrested by serum
deprivation and contact inhibition, then stimulated to re-enter the cell cycle
by passaging them into serum-containing medium. Changes in the expression
of cyclin D1, D2, and D3 mRNAs were analyzed by real-time RT-PCR (a–c) at the
times indicated after release from cell quiescence. Values are shown as relative
expression compared to 0hour sample (mean7SD, *Po0.05, Dunnett’s test).
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positive staining. For D3 protein expression only a slight
increase was detected in the cells at 72 and 96 hours
compared to the 0 hour level (1.6- and 1.57- fold increase
in GeoMean); however, 66.0876.67% cells were positive for
cyclin D3) (Figure 2c).
Neither cell morphology nor proliferation, is affected by cyclin
D1 gene-specific silencing in HaCaT keratinocytes released
from cell quiescence
Next, we addressed the question whether cyclin D1 function
was essential for the quiescent HaCaT keratinocytes to
proliferate after release from contact inhibition and serum
starvation. HaCaT keratinocytes were contact-inhibited for
1 day and serum-starved for 5 days. Cells were then harvested
and nucleofected with cyclin D1 small-interfering RNA
(siRNA) in suspensions and then plated and cultured. Two
independent experiments were carried out, and both gave
similar results. The transfection efficacy was 71.37 and
90.24%. We show the results of the second experiment
where the transfection efficacy was 90.24%. Cyclin D1, D2,
and D3 mRNAs were determined at 24, 48, and 72 hours
after transfection. Control cultures were treated similarly and
transfected with mock siRNA for cyclin D1 or not transfected.
As expected, D1 siRNA significantly downregulated cyclin
D1 expression in the transfected HaCaT keratinocytes at 24,
48, and 72 hours after the plating of the cells (Figure 3a).
Silencing of D1 mRNA expression had no effect on the D2
and D3 mRNA expressions (Figures 3b and c). Cell numbers
determined by thiazolyl blue tetrazolium bromide assay at
the same time points were similar in all cultures (Figure 3d).
Cell and colony morphology in D1 cyclin silenced HaCaT
cultures did not show any obvious difference compared to
both controls (Figure 4).
Cyclin D2 and D3 but not cyclin D1 mRNA expressions are
significantly increased in psoriatic lesional epidermis, but the
proportions of cyclins D2, D3, and D1 protein expressing cells
are not changed
Because psoriasis is a skin disease characterized by abnormal
proliferation of the normally quiescent basal keratinocytes,
we aimed to compare the expression of cyclins D1, D2, and
D3 in psoriatic lesional, non-lesional, and healthy epidermis.
We performed real-time RT-PCR and flow cytometric analysis
on independent healthy (n¼ 6), psoriatic uninvolved (n¼ 6),
and involved (n¼6) epidermal samples. Results of the real-
time RT-PCR analysis revealed no difference in cyclin D1
mRNA expression among normal, lesional, and non-lesional
epidermis (Figure 5a). Cyclin D2 mRNA showed a signifi-
cantly higher expression (8.61-fold) in lesional psoriatic
epidermis compared to normal epidermis (Figure 5b).
Although a 3.94-fold increase was also detected between
the psoriatic non-lesional and lesional epidermis in cyclin D2
mRNA expression, the difference here was not significant
(Figure 5b). Cyclin D3 mRNA expression was significantly
higher in lesional epidermis compared to both non-lesional
psoriatic (2.41-fold increase; Figure 5c) and normal epidermis
(2.92-fold increase; Figure 5c).
Flow cytometry showed that among epidermal cells
separated from normal, psoriatic lesional, and non-lesional
epidermis, a low percentage of cells (2.2870.8, 6.8373.69,
and 0.2570.04% of all cells) expressed cyclin D1. D2- type
cyclins were expressed by a similar very low percentage of
cells (472.95, 10.470.66, and 0.970.16% of all cells),
whereas cyclin D3 protein was expressed by a larger
percentage of cells (59.3175.2, 29.776.8, and 37.5710%
of all cells). We found no difference in cyclin D protein
expression among normal, lesional, and non-lesional psor-
iatic epidermis samples by flow cytometric analysis compar-
ing the GeoMean results (Figure 6).
The absolute numbers of cyclin D1 expressing cells are
increased in psoriatic lesional tissue, whereas the expression of
cyclin D3 protein in lesional psoriatic epidermis appears similar
to normal epidermis
Although we found no difference in cyclin D1 expression
when we analyzed epidermal cell suspensions by flow
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Figure 2. Cyclin D1, D2, and D3 protein expressions in synchronized HaCaT
keratinocytes. HaCaT keratinocytes (n¼ 3) were synchronized by contact
inhibition and serum starvation (0 hour), and then released from cell
quiescence by serum re-addition and passage. Flow cytometric analysis was
used to detect the expression of (a), cyclin D1, (b) D2, and (c) D3 proteins in
the cells at the indicated times. The geometric mean fluorescence intensity
(GeoMean) was calculated by subtraction of the GeoMean of isotype-stained
cells from the GeoMean of the specific antibody-stained cells using CellQuest
Software (mean7SD, *Po0.05, Dunnett’s test).
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cytometry, immunohistochemical staining showed increased
numbers of cyclin D1 expressing keratinocytes in the basal
layers of the lesional epidermis (Figure 7c) compared to
normal (Figure 7a) and non-lesional (data not shown)
epidermis. In healthy epidermis, immunohistochemical
detection showed distinct nuclear staining, but only rare
isolated cells in the basal, immediately suprabasal cell
compartments were positive for cyclin D1 (Figure 7a arrows).
Cyclin D3-positive staining, both nuclear and cytoplasmic, in
normal epidermis could be detected only in the suprabasal
layers of the hair follicles (Figures 7b and d arrows), whereas
it showed negative staining in the interfollicular region (data
not shown). In the lesional psoriatic epidermis, many more
cells in the basal and immediate suprabasal compartment
showed nuclear as well as cytoplasmic staining for cyclin D1
(Figure 7c). The proportion of cyclin D3 expressing cells
showing nuclear and cytoplasmic staining was similar in
lesional psoriatic skin compared to normal skin. We were not
able to detect cyclin D2 expression by immunohistochemical
analysis in any of the examined psoriatic and normal skin
sections. This negative result was not due to technical
constraints, because with the same method using the same
antibody we detected very clear positive stainings in skin
tumors (data not shown).
Blocking of a5-integrin function results in a significant decrease
of cyclin D1 mRNA expression in synchronized HaCaT
keratinocytes
We were next interested in seeing whether a5-integrin-
mediated signal transduction events could regulate the
mRNA expression of cyclin D1 in the postquiescent HaCaT
keratinocytes. HaCaT keratinocytes were synchronized as
described and after harvest they were seeded onto culture
plates. When cells were already attached and spread on the
plates, about 5 hours after seeding, we added a purified
mouse anti-human a5-integrin neutralizing monoclonal
antibody and an isotype control antibody to the cultures.
Cells were then further cultured, and 12 hours after release
from cell quiescence cyclin D1 mRNAs were measured using
real-time RT-PCR analyses (n¼ 3). The mRNA expression
of cyclin D1 was significantly inhibited in the specific
antibody-treated cultures compared both to the untreated
control cells and the isotype-matched immunoglobulin-
treated cells (Figure 8). The specific antibody treatment had
no influence on the cyclin D2 and D3 expressions of the cells
(data not shown).
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Figure 3. Gene-specific silencing by siRNA effectively downregulates the expression of cyclin D1 and does not affect cell viability of synchronized
HaCaT keratinocytes. Contact-inhibited and serum-starved cyclin D1 siRNA, control siRNA-transfected and -untransfected HaCaT keratinocytes were
cultured for 24, 48, and 72 hours. (a) Cyclin D1, (b) D2, and (c) D3 mRNA expressions were determined by real-time RT-PCR. Data are indicated as fold
expressions compared to the 24 hours untransfected sample. Values shown are from a representative experiment. Cell viability was measured by thiazolyl
blue tetrazolium bromide assay. Data are indicated as absorbance values measured at 540 nm. (d) Values shown are from the same representative
experiment.
siD1 siK K
Figure 4. Gene-specific silencing by cyclin D1 siRNA does not alter the
morphology of HaCaT keratinocytes. Contact-inhibited and serum-starved
cyclin D1 siRNA, control siRNA-transfected and -untransfected HaCaT
keratinocytes were cultured for 72 hours after passaging. Cell morphology
was detected by a Nikon Eclipse TS100 microscope and photographed
by a Nikon Coolpix 4500 digital camera. Bar¼50 mm.
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DISCUSSION
D-type cyclins are rate-limiting factors of the G1 progression.
Several reports suggest that D-type cyclins have non-
overlapping functions in cell-cycle regulation in specific cell
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Figure 5. Cyclin D1, D2, and D3 mRNA expressions in psoriatic lesional,
non-lesional, and normal epidermis. The expression of (a) cyclin D1, (b) D2,
and (c) D3 mRNAs was analyzed by real-time RT-PCR in healthy (n¼ 6),
psoriatic uninvolved (n¼ 6), and involved (n¼ 6) epidermal samples. Values
are shown as relative expression compared to healthy epidermis (mean7SD,
*Po0.05, Student’s t-test).
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Figure 6. Cyclin D1, D2, and D3 protein expressions in psoriatic lesional
and normal epidermis. The expression of cyclin D1, D2, and D3 proteins was
analyzed by flow cytometry in healthy (n¼ 6), psoriatic uninvolved (n¼6),
and involved (n¼6) epidermal samples. The geometric mean fluorescence
intensity (GeoMean) was calculated by the subtraction of the GeoMean of the
cells stained with isotype-matched control immunoglobulin from the
GeoMean of cells stained with antigen-specific antibody, using CellQuest
software. Values represent mean7SD.
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Figure 7. Immunohistochemical detection of cyclin D1 and D3 proteins
in healthy and psoriatic lesional epidermis. (a) Cyclin D1-positive cells are
rare, and show distinct nuclear staining in the basal layer of normal epidermis.
(c) Intense cyclin D1 nuclear and a slight cytoplasmic staining can be
detected in many more basal as well as suprabasal cells of the lesional
psoriatic epidermis. Cyclin D3 staining is localized to the cytoplasm and
nucleus, and detected only in the suprabasal cells of the hair follicles, both in
(b) normal and in (d) psoriatic lesional skin. Bar¼50 mm.
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Figure 8. Blocking the function of a5-integrin immediately after surface
attachment in synchronized HaCaT keratinocytes leads to the
downregulation of cyclin D1 mRNA expression. A neutralizing monoclonal
antibody to human a5-integrin was added to already attached, synchronized
HaCaT keratinocytes 5 hours after release from cell quiescence and cells were
further cultured. The effect of neutralizing antibody on cyclin D1 mRNA
expression was detected by real-time RT-PCR analysis. Values are indicated
as relative expression compared to 0 hour untreated sample (n¼ 3)
(mean7SD, *Po0.05, Mann–Whitney U-test).
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types. Cyclin D1-mediated proliferation predominantly
occurs in the immediate progeny of the stem cell-rich bulge
cells in the human hair follicle, indicating that cyclin D1 may
be important for cells to exit the stem-cell compartment (Xu
et al., 2003) and cyclin D3 accumulates to high levels in the
stratified squamous epithelial layers of postreplicative,
differentiating cells but not in the superficial, terminally
differentiated ones (Bartkova et al., 1998). In normal human
keratinocyte cultures, when quiescent (G0) K1/K10
 kerati-
nocytes traverse into the first cell cycle, they express cyclin
D1, but not D2, as determined by antibody staining and flow
cytometric analysis. As keratinocytes go into subsequent cell
cycles in the in vitro culture, D1 protein expression
disappears and cyclin D2 expression becomes clearly
detectable. Corresponding to the lack of protein expression,
cyclin D1 mRNA is not detectable 24 hours after plating, but
it is clearly present as cells go into the first round of cell cycle
(3–4 day cultures) and decreases in the subsequent cell cycles
(Bata-Csorgo et al., 1996). In normal human skin, a large
number of keratinocytes express cyclin D1 in the basal and
immediately suprabasal layer when they are induced to
hyperproliferate 72 hours after a 2 MED UVB irradiation (data
not shown).
We obtained similar results in immortalized keratinocytes
(HaCaT), where the expression of cyclin D1 both at the
mRNA and protein levels has increased in cells after leaving
the G0 quiescent phase and cyclin D2 and D3 expressions
occurred in already cycling cells.
Although HaCaT keratinocytes showed differential expres-
sion in the synchronized culture, cyclin D1 gene-specific
silencing had no effect on the proliferation and morphology
of HaCaT keratinocytes during the interval between cellular
quiescence and intense proliferation after release from
quiescence. We did not detect a compensatory increase in
silenced cells for the remaining D-type cyclin mRNAs. It has
been shown that the lack of cyclin D1 expression does result
in significant reduction in mouse skin and mammary tumor
development. However, complete elimination of tumor
development was not observed in these models, suggesting
that other cyclin/cdk complexes may partially compensate for
the loss of cyclin D1 function (Robles et al., 1998). It is also
known that in knock-in mice expressing cyclin D2 in place of
cyclin D1, cyclin D2 can replace cyclin D1’s functions
(Carthon et al., 2005). Our results also indicate that cyclins
D2 and D3 could substitute for D1 in driving keratinocyte
cell cycle.
Increasing data suggest that D-type cyclins have multiple
functions besides cell-cycle regulation. Cyclin D3 was
ubiquitously expressed in 70 different human cultured cell
types, whereas D1 and D2 were not. Complementary
analyses of human and mouse tissues at different stages of
fetal and postnatal development revealed a correlation
between cyclin D3 abundance and mature-differentiated
phenotypes, indicating a possible role for cyclin D3 in the
induction and maintenance of terminal differentiation (Bart-
kova et al., 1998). In previous work using the same
synchronized HaCaT keratinocyte model, we found that the
highly proliferating, cyclin D1 expressing, immediately
postquiescent cells downregulate the early differentiation
markers K1/10 at the mRNA levels (Pivarcsi et al., 2001).
Overexpressed cyclin D1 in HaCaT keratinocytes results in
deregulation of tissue architecture with altered localization
and impaired differentiation; these cells lack terminal
differentiation and exhibit a more autonomous growth,
even form keratoacanthoma-like tumors in vivo (Burnworth
et al., 2006).
HaCaT cells, although immortalized and genetically
abnormal, are considered to be a good model for human
keratinocytes. With their high proliferative potential, they
especially resemble keratinocytes found in the skin disease
psoriasis. Psoriasis can be characterized with an excessive
basal-cell proliferation and perturbed keratinocyte differen-
tiation, which are regarded as central pathologic features of
the disease. Because hyperproliferation in the psoriatic
epidermis is due to activation of the normally quiescent cells
in the b1 integrinþ K1/K10 basal-cell compartment (Bata-
Csorgo et al., 1993), we expected the expression of D1-type
cyclin to be increased both at the mRNA and protein levels in
psoriatic epidermis. Contrary to our expectation, we detected
a significant increase in cyclin D2 and D3 mRNA expressions
in chronic plaques of lesional psoriatic epidermis compared
to normal epidermis, but the expression of cyclin D1 mRNA
showed no difference. By flow cytometric analysis, the
percentage of cells expressing cyclins D1, D2, and D3 was
similar in the psoriatic epidermis as in the normal and the
non-lesional epidermis. The percentage of D1 and D2 protein
expressing cells was low relative to the percentage of D3
protein expressing cells in all samples. This result is similar to
our previous observation showing that the increased number
of cycling keratinocytes in the psoriatic b1 integrinþ K1/
K10 basal compartment did not result in an overall increase
in the size of this cell compartment, indicating that the
proportion of b1 integrinþ K1/K10 cells that self-renew (to
b1-integrin K1/K10 cells) is the same in psoriatic epidermis
as it is in normal epidermis, and that excess cells are
committed toward differentiation (Bata-Csorgo et al., 1993).
Immunostaining of tissue sections revealed that the
psoriatic lesional epidermis contained more cells in absolute
numbers that showed distinct nuclear and some cytoplasmic
expression of cyclin D1 protein than the normal and psoriatic
non-lesional epidermis where we could detect only nuclear
staining in a few basal layer cells. (Xu et al., 2003) found that
cyclins D1, D2, and D3 were not detectable by immunohis-
tochemistry in the rapidly proliferating hair-producing cells of
the anagen bulb while these cells were strongly positive for
Ki-67 and retinoblastoma protein. Contrary to these data, we
found that cyclin D3 protein was expressed in the cytoplasm
and nucleus of the suprabasal cells in the hair follicles and
the proportion of positively stained cells seemed to be similar
in the psoriatic lesional, non-lesional, and normal epidermis.
We used different antibodies for flow cytometry and
immunohistochemistry because neither of the antibodies
were suitable for both methods. We could not detect cyclin
D2 in normal and lesional psoriatic epidermis by immuno-
histochemistry although some skin tumors (squamous-cell
carcinoma and melanoma) that we stained with the same
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antibody showed clear positive immunostaining of cyclin D2
(data not shown).
Besides transcriptional and post-transcriptional regulation,
the expressions of D-type cyclins are regulated by targeted
degradation via the ubiquitin pathway (Diehl et al., 1998;
Chung et al., 2006; Okabe et al., 2006; Yang et al., 2007).
The fact that there are more cyclin D1-positive cells in the
stable psoriatic lesion localized both in the basal and in the
immediate suprabasal compartment of the epidermis, at the
same time no increase in D1 mRNA can be detected in the
psoriatic samples, indicate a possible dysfunction in the
degradation of cyclin D1 in this disease, which could be
partially responsible for keratinocyte hyperproliferation and
abnormal differentiation of the basal keratinocytes. It is
possible that by retaining cyclin D1 expression, the highly
proliferative b1-integrinþ K1/K10 basal compartment ker-
atinocytes in the psoriatic epidermis protect their stem-cell
potential. Indeed, primary cultured keratinocytes with in-
duced cyclin D1 transgene expression show resistance to
calcium-induced terminal differentiation and continue to
replicate in vitro (Yamamoto et al., 2002). The significant
increase in the relative expressions of cyclin D2 and D3
mRNAs in the psoriatic lesional epidermis with no change in
protein expressions indicates post-transcriptional dysregula-
tion of these cyclins in psoriatic keratinocytes.
It is well documented that in the skin, as in other tissues,
keratinocyte integrins are important regulatory molecules in
epidermal homeostasis. The main receptor of fibronectin, a5-
integrin, is abnormally overexpressed in uninvolved kerati-
nocytes of the in vivo psoriatic epidermis (Bata-Csorgo et al.,
1998) and the A domain of fibronectin (EDAþ ) is present at
the basement membrane zone of uninvolved psoriatic skin
while absent in normal control skin (Ting et al., 2000). Upon
in vitro activation there is enhanced EDAþ fibronectin
expression in psoriatic uninvolved keratinocytes compared
to normal cells (Szell et al., 2004). The finding that a5-
integrin regulates cyclin D1 mRNA expression in quiescent
HaCaT keratinocytes indicate that the abnormally active
fibronectin-a5-integrin ligand–receptor-induced pathway in
the psoriatic non-lesional keratinocytes could contribute to
keratinocyte hyperproliferation in psoriasis. That cyclin D1
expression is dependent on intact a5-integrin function has
also been indicated in the keratinocyte-derived SCC12 cells,
in which binding of the ganglioside GT1b to a5-integrin
inhibited the expression of cyclin D1 (Wang et al., 2001).
We conclude that the regulatory functions of D-type
cyclins in keratinocytes are not completely redundant.
Although knocking down cyclin D1 in quiescent keratino-
cytes does not result in immediate changes in cell morphol-
ogy and proliferation, both the differential expression of these
cyclins in cultured keratinocytes and their abnormal expres-
sion in stable plaques of psoriasis suggest that they may have
other specific functions besides driving the cell cycle in the
cells. Our data also suggest a possible role for D-type cyclins
in the excessive basal-cell proliferation and perturbed
keratinocyte differentiation that occurs in the psoriatic
epidermis. In preliminary experiments, we have found that
in our HaCaT keratinocyte model system, the antipsoriatic
1,25-dihydroxyvitamin D3 had an effect on all D-type cyclin
mRNA expression (data not shown), indicating that D-type
cyclins could be the target of therapies in psoriasis.
MATERIALS AND METHODS
Cell culture
The spontaneously immortalized human keratinocyte cell line,
HaCaT, kindly provided by Dr. N.E. Fusening (Heidelberg,
Germany), was grown in 75 cm2 cell culture flasks (Corning
Incorporated, Corning, NY) and maintained in high-glucose DMEM
(Gibco, Eggstein, Germany), supplemented with 10% fetal bovine
serum (HyClone, Perbio, Budapest, Hungary), L-glutamine, and
antibiotic/antimycotic solution containing 100U/ml penicillin,
100ml/ml streptomycin, and amphotericin B (Sigma, Steinheim,
Germany) at 371C in a humified atmosphere containing 5% CO2.
The medium was changed every second day.
Human tissue samples
Shave biopsies were taken from uninvolved and involved skin of
psoriatic patients from the buttock area. Control skin biopsies from
the breast and the stomach area were obtained from healthy
individuals undergoing plastic surgery. After removal of the
subcutaneous tissue, skin biopsies were incubated overnight at 41C
in Dispase solution (grade II; Roche Diagnostics, Mannheim,
Germany). On the following day, the epidermis was separated from
the dermis. All tissue samples were taken with the patient’s informed
consent and the approval of the local ethics committee. The study
was conducted according to the Declaration of Helsinki Principles.
Synchronization procedure
HaCaT keratinocytes were synchronized and cultured as described
previously (Pivarcsi et al., 2001). Samples were collected 0, 12, 24,
36, 48, 72, 96, and 168 hours after the end of the synchronization
process.
Real-time RT-PCR
Total RNA was isolated from epidermis obtained from shave biopsies
after Dispase digestion and from HaCaT keratinocytes using TRIzolTM
reagent (Gibco, Invitrogen, Carlsbad, CA) following the manufac-
turer’s instructions. RNA concentration was determined by measur-
ing the A260 values. First-strand cDNA was synthetized from 1mg of
total RNA using the iScriptTM cDNA Synthesis Kit from Bio-Rad
(Hercules, CA). Real-time RT-PCR experiments were performed to
quantify the relative abundance of each mRNA by using the iCycler
IQ Real-Time PCR machine of Bio-Rad. Primers specific cyclin D1
(cat. no. Hs 00277039), D2 (cat. no. Hs 00153380), and D3 (cat. no.
Hs 00236949) were purchased from Applied Biosystems (Foster City,
CA). The abundance of each gene of interest was normalized to the
expression of 18S ribosomal RNA of each examined sample. The
primers for 18S were 18S RNA forward: CGGCTACCACATCCAAG
GAA, 18S RNA reverse: GCTGGAATTACCGCGGCT, 18S RNA
TaqMan probe: TexRed-TGCTGGCACCAGACTTGCCCTC-BHQ-1
(Integrated DNA Technologies, Coralville, IA).
Flow cytometric analysis of freshly separated epidermal cells
and HaCaT keratinocytes
The epidermis was separated from the dermis as described
previously. Epidermal and HaCaT keratinocyte suspensions were
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prepared using trypsin (0.25% for epidermal and 0.025% for HaCaT
cells). Cells were fixed in 201C cold 70% ethanol (Reanal,
Budapest, Hungary) and kept at 201C for at least overnight before
staining. The monoclonal antibodies used were as follows: purified
mouse anti-human cyclin D1; purified mouse anti-human cyclin D2;
and purified mouse anti-human cyclin D3 at 1:200 dilution, all from
BD Pharmingen (San Diego, CA), mouse IgG1, mouse IgG2a, and
mouse IgG2b at the same concentrations served as isotype controls
(all from Sigma). Secondary antibodies were anti-mouse IgG1, IgG2a,
and IgG2b coupled with fluorescein isothiocyanate, used at 1:50 and
mouse IgG2b at 1:500 dilutions all were from BD Pharmingen). Cells
(500,000) were washed in PBS containing 0.5% BSA (Sigma) and
0.1% Triton-X (Reanal), and then incubated with the primary
antibody at 41C overnight. After being washed in PBS containing
0.1% Triton-X, cells were incubated for 30minutes at room
temperature with the fluorescein isothiocyanate-conjugated second-
ary antibodies. Analysis was carried out using a FACScalibur flow
cytometer (Becton Dickinson, San Jose, CA) and CellQuest software
(Becton Dickinson). Results were expressed either as the geometric
mean fluorescence intensity (GeoMean) calculated by substraction
(GeoMean of the antigen-specific antibodies stained cells –
GeoMean of isotype-matched control antibodies stained cells), or
as percentage of positive cells.
Gene silencing by siRNA
HaCaT keratinocytes were contact-inhibited for 1 day and serum-
starved for 5 days. Cells were then harvested and nucleofected with
cyclin D1 siRNA by NucleofectorTM II (Amaxa Biosystems, Koeln,
Germany) using V-Kit optimized for HaCaT keratinocytes (VCA-
1003; Amaxa Biosystems) in suspensions and then plated to 12-well
tissue culture plates and cultured in antibiotic-free medium contain-
ing 10% fetal bovine serum and incubated at 371C. Cyclin D1 siRNA
(sc-29286) and control siRNA (sc-36869) were from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA) and were used following the
manufacturer’s instructions. Samples were taken at 24, 48, and
72 hours after the passage of the cells. Control siRNA is a non-
targeting 25 nt siRNA designed as a transfection control. Total RNA
was isolated using TRIzol reagent (Invitrogen). Real-time RT-PCR
was carried out as described above to quantify the mRNA expression
of cyclins D1, D2 and D3. The transfection efficacy was detected
using a plasmid encoding the enhanced green fluorescent protein
(Amaxa Biosystems) 48 hours post-transfection by flow cytometry.
Thiazolyl blue tetrazolium bromide assay
HaCaT keratinocytes were contact-inhibited for 1 day and serum-
starved for 5 days. Cells were then trypsinized and nucleofected in
cell suspension with cyclin D1 siRNA. HaCaT keratinocytes were
seeded into wells of 96-well plates directly after transfection at a
density of 5 103 cells/well and grown in 200 ml complete high-
glucose DMEM medium for 24, 48, and 72hours. Thiazolyl blue
tetrazolium bromide assays were carried out as described previously
(Sonkoly et al., 2005).
Immunohistochemical staining
Formalin-fixed, paraffin-embedded tissue sections were dewaxed.
Slides were placed in a slide rack and immersed into 500ml of
10mM citric acid buffer (pH 6.0). After incubation in a microwave
oven for 30minutes at 700W, during which the incubation solution
boiled for about 25minutes, slides were rinsed with Tris-buffered
saline (Sigma), containing 0.1% Triton-X (Reanal) for 15minutes.
Nonspecific staining was prevented by preincubation with 0.5%
bovine serum albumin diluted in Tris-buffered saline (Sigma),
containing 0.1% Triton-X (Reanal) for 30minutes at room tempera-
ture in a humid chamber. Cells were then incubated overnight at 41C
in a humid chamber with the primary antibodies. Purified mono-
clonal antibodies to cyclins D1, D3 (NeoMarkers, Fremont, CA), and
D2 (Fitzgerald Industries Int. Inc., Concord, MA, USA) were applied
at 1:200, 1:25, and 1:2 dilutions, respectively, rabbit IgG (NeoMarkers),
mouse IgG1, and mouse IgG2a (Sigma) were used for isotype control
stainings. Slides were then incubated with a biotinylated secondary
antibody (anti-rabbit IgG for cyclin D1, anti-mouse IgG for cyclins
D2 and D3 all at 3.3 mg/ml concentration) for 1 hour at room
temperature, followed by incubation with horse radish peroxidase-
conjugated streptavidin for 1 hour at room temperature (Vectastain
ABC Kit; Vector, Burlingame, CA), and finally peroxidase activity
was detected using 3,3 amino-9 ethylcarbazole (Sigma) as a
substrate. Slides were counterstained with hematoxylin (Sigma).
Tissue staining was visualized using a Zeiss Axio Imager microscope
and photographed using a PixeLINK digital camera.
a5-integrin blocking assay
A total of 1 106 synchronized HaCaT keratinocytes were seeded into
25cm2 cell culture flasks (Sarstedt, Germany). Fivehours after seeding,
when the cells were already attached to the surface of the culture flask, an
a5-integrin neutralizing purified mouse anti-human monoclonal antibody
(CD49e, no azide-low endotoxin; BD Pharmingen) was added to the cells
at a final concentration of 20mg/ml. Mouse IgG1 (BD Pharmingen) at
identical concentration was used for isotype control. HaCaT keratinocytes
were incubated with the antibody for 7hours. Samples were collected
before (0hour) and 12hours after the seeding of the cells. Total RNA was
isolated using TRIzol reagent (Invitrogen) following the manufacturer’s
instructions. Samples were analyzed by real-time RT-PCR to quantify the
mRNA expression of cyclins D1, D2, and D3.
Data presentation
Gene expression results were expressed as fold increases over
control values. Data were presented as mean7SD for n experiments.
Flow cytometry data were expressed either as percentage over
isotype values or as the geometric mean fluorescence intensity
(GeoMean) calculated by subtraction of the GeoMean of isotype-
stained cells from the GeoMean of the specific antibody-stained
cells. Data were compared using one-way analysis of variance
followed by Dunnett’s post hoc test to determine statistical
differences after multiple comparisons (SPSS, SPSS Inc., Chicago,
IL). Data from the a5-integrin blocking assay were compared using
the Mann–Whitney U-test. P- values of less than 0.05 for both
parametric and non-parametric tests were considered significant.
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